Pembrolizumab-Induced Myositis: Diagnostic and Therapeutic Challenges From Two Case Reports and a Narrative Review
{{output}}
Background: Pembrolizumab, an anti-PD-1 immune checkpoint inhibitor, has transformed the treatment of multiple solid tumors. However, it can rarely cause immune-related myositis, which may involve limb, bulbar, and respiratory mu... ...
